Sign In
Buy EVLO
$0.0001
+0 (+0%)
At Close: Jun 22, 2026
Evelo Biosciences Closes $25.5 Million Private Placement
07:30am, Wednesday, 12'th Jul 2023
Restructures and reduce s secured debt with Horizon Technology Finance Corporation Appoints two new members and decreases size of Board of Directors
Evelo Biosciences Announces $25.5 Million Private Placement
07:30am, Monday, 10'th Jul 2023
CAMBRIDGE, Mass., July 10, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolving
Why Is Evelo Biosciences (EVLO) Stock Up 51% Today?
08:20am, Tuesday, 20'th Jun 2023
Evelo Biosciences (NASDAQ: EVLO ) stock is rising higher on Tuesday after the clinical-stage biotechnology company reached a new standstill agreement with Horizon Technology Finance (NASDAQ: HRZN ) la
What Makes Evelo Biosciences, Inc. (EVLO) a New Buy Stock
01:33pm, Wednesday, 17'th May 2023
Evelo Biosciences, Inc. (EVLO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Discover the Top Penny Stock Technical Indicators By Effectiveness
06:00am, Friday, 28'th Apr 2023
Use these technical indicators to profit with penny stocks The post Discover the Top Penny Stock Technical Indicators By Effectiveness appeared first on Penny Stocks to Buy, Picks, News and Informatio
Why Is Evelo Biosciences (EVLO) Stock Up 78% Today?
08:01am, Thursday, 27'th Apr 2023
Evelo Biosciences (NASDAQ: EVLO ) stock is on the rise Thursday after the company said it's shifting focus toward extracellular vesicle (EV) development. With this news, Evelo Biosciences will put a g
Evelo Biosciences, Inc. (EVLO) Q4 2022 Earnings Call Transcript
11:24am, Thursday, 16'th Mar 2023
Evelo Biosciences, Inc. (NASDAQ:EVLO ) Q4 2022 Earnings Conference Call March 16, 2023 8:30 AM ET Company Participants Shamira Shariffudin - Director Business Development Simba Gill - Chief Executive
Forget Bargain Hunting, Buy 4 Stocks With Rising P/E
08:28am, Thursday, 16'th Mar 2023
Tap four stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include James River Group (JRVR), MakeMyTrip Limited (MMYT), Evelo Biosciences (EVLO) and The Kroger Co.
Evelo Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, March 16, 2023
06:00am, Thursday, 09'th Mar 2023
CAMBRIDGE, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered inflammation-resolvi
After Plunging -40.39% in 4 Weeks, Here's Why the Trend Might Reverse for Evelo Biosciences, Inc. (EVLO)
11:18am, Wednesday, 01'st Mar 2023
Evelo Biosciences, Inc. (EVLO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analys
Down -39.46% in 4 Weeks, Here's Why Evelo Biosciences, Inc. (EVLO) Looks Ripe for a Turnaround
11:17am, Monday, 13'th Feb 2023
The heavy selling pressure might have exhausted for Evelo Biosciences, Inc. (EVLO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall St
Evelo Biosciences to Present at the 2022 Jefferies London Healthcare Conference
06:00am, Tuesday, 08'th Nov 2022
CAMBRIDGE, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on t
Evelo Biosciences, Inc. (EVLO) CEO Simba Gill on Q2 2022 Results - Earnings Call Transcript
11:55pm, Thursday, 11'th Aug 2022
Evelo Biosciences, Inc. (NASDAQ:EVLO ) Q2 2022 Earnings Conference Call August 11, 2022 7:30 AM ET Company Participants Kendra Sweeney - Investor Relations Simba Gill - Chief Executive Officer Ara Dar
Evelo Biosciences to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022
06:00am, Friday, 05'th Aug 2022
CAMBRIDGE, Mass., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered medicines acting on t
Evelo Biosciences Shares Gain After Positive Data On Faster Release EDP1815 Capsule, Q4 Earnings
12:51pm, Thursday, 24'th Mar 2022
In the Q4 earnings release, Evelo Biosciences Inc (NASDAQ: EVLO) shared results from an ongoing Phase 1 single-center trial in healthy volunteers that showed that a capsule with an improved release
